Comparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patients With Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

February 17, 2015

Primary Completion Date

February 28, 2019

Study Completion Date

February 28, 2019

Conditions
Stage I Breast CancerStage II Breast Cancer
Interventions
DRUG

Indocyanine Green Solution

Given subdermally

RADIATION

Technetium Tc-99m Sulfur Colloid

Given via injection

PROCEDURE

Lymphoscintigraphy

This is a method used to check the lymph system for disease. A radioactive substance that flows through the lymph ducts and can be taken up by lymph nodes is injected into the body. A scanner or probe is used to follow the movement of this substance on a computer screen. Lymphoscintigraphy is used to find the sentinel lymph node (the first node to receive lymph from a tumor), which may be removed and checked for tumor cells. Lymphoscintigraphy is also used to diagnose certain diseases or conditions, such as lymphoma or lymphedema.

PROCEDURE

Axillary Lymph Node Biopsy

Undergo biopsy

Trial Locations (1)

44195

Cleveland Clinic Taussig Cancer Instititute, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Mitaka USA, Inc.

INDUSTRY

lead

Case Comprehensive Cancer Center

OTHER

NCT02419807 - Comparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patients With Breast Cancer | Biotech Hunter | Biotech Hunter